showed a trendP = 0.001
Moreover, the LGE extent were related to the levels of NT-proBNP and showed a trend with increasing NT-proBNP ( r = 0.399, P = 0.001).
Moreover, the LGE extent were related to the levels of NT-proBNP and showed a trend with increasing NT-proBNP ( r = 0.399, P = 0.001).
Moreover, in patients diagnosed with acute coronary syndrome (ACS), higher TyG index levels showed a trend of increased risk of MACE (HR = 1.54; 95% CI: 1.27–1.86; P < 0.001).
Compared to the echocardiography at 7 days, IVST and LVPWd at 6 months after treatment showed a trend to incrassation in the control group (9.6 ± 0.3 vs. 9.9 ± 0.4, P < 0.001; 9.6 ± 0.3 vs. 9.9 ± 0.5, P < 0.001) and had no significant change in the TPE group (9.6 ± 0.4 vs. 9.7 ± 0.4, P = 0.251; 9.5 ± 0.3 vs. 9.7 ± 0.2, P = 0.056), while LVIDd were found to be significantly decreased in the TPE group (45.4 ± 2.8 vs. 44.0 ± 1.5, P = 0.019) and had no significant change in the control group (45.0 ± 2.9 vs. 44.6 ± 3.0, P = 0.244).
Concerning principal diagnosis, F0, F1, and F7 tended to have shorter hospital stays, while F2 showed a trend toward fewer short-term hospitalizations (χ 2 = 245.869, P < 0.001).
In addition, BCVA (LogMAR) showed a trend of time-dependent decrease from postoperative 1 day to 3 months ( P < 0.001) (Fig. 3 ).
Three LMD tissues had a sufficient number of stromal cells to examine the changes in the tumor SERPINA3 expression at increasing distance intervals from the stroma, and all three tissues showed a trend of expression decreasing at intervals further away from the stroma ( p < 0.001, p = 1, and p < 0.001 for samples 7, 2, and 8, respectively, Figure S5 B).
In vitamins, only thiamine showed a trend towards higher consumption with higher UP food consumption ( p < 0.001).
For the region of Campinas, the number of cases of CIN3 and AIS registered yearly over time was compared with the cancer registries and showed a trend towards increase (121 cases in 2001 and 177 cases in 2012, p < 0.001) ( Fig. 1 , dotted line).
Signal Phase Intensity The average intensity of the signal phase showed a trend of decreasing with decreasing dosage at time point T1 ( p -value < 0.001).
were present in all samples, across time they showed a trend of higher abundance within amended samples with a significant difference at Time 2 ( p < 0.001) (Time 0—BBFs: av. 0.6%, ABBFs: 8.8%; Time 1—BBFs: av. 0.5%, ABBFs: 1.7%; Time 2—BBFs: av. 0.7%, ABBFs: 1.5%).
11 ) in the presence of FABP1 because the apparent K m for 4’-OH-diclofenac formation by CYP2C9 in the presence of hFABP1 (5.8 ± 1.5 μ M) only showed a trend for an increase ( P = 0.0011, 0.0729, 0.0416 for paired replicate experiments) when compared with in the absence of hFABP1 (1.4 ± 0.2 μ M) ( Supplemental Fig. 11 ; Table 2 ).
Both concentrations of FermCAE also showed a trend towards better antioxidant activity compared to respective concentrations of AQE, with a significant difference between the 2.5% extract groups ( p = 0.0014).
The IVW analysis showed a trend-causing relationship between the brain cortex surficial area and succinylcarnitine levels ( β = 2.62 × 10 −05 , CI: 9.62 × 10 −06 to 4.24 × 10 −05 , p = 0.0019).
Meanwhile, patients in the ACDF group showed a trend of significantly higher BMI (ACDF/LAMP = 30.72/29.57, p = 0.0027), preoperative dyspnea (ACDF/LAMP = 7.24%/2.74%, p = 0.0004), and lower preoperative hematocrit (ACDF/LAMP = 40.79/41.86, p < 0.0001) compared with the LAMP group ( Table 1 ).
On multivariate analysis, a lower PNI (< 44.91) and worse response rate (SD + PD) showed a trend toward reduce PFS (P = 0.003 and P < 0.001).
In particular, the gintonin (GT 100)-treated group showed a trend similar to that of the ranitidine-treated group ( p = 0.004, Cohen’s d = 2.1 and p = 0.024, Cohen’s d = 1.5, respectively), in which the blood vessels were close to those of the normal group.
While the peri-procedural complication rates showed a trend to lower numbers for all other complications between 2016 and 2019, a significant decrease by 97% [95% CI 0–0.24] was determined for SE ( p = 0.004) ( Figure 2 , Table 2 and Table S1 ).
Included patients showed a trend of worse EFS and OS post-ASCT (EFS: HR = 3.21, 95% CI 1.43–7.21, p = 0.0047; OS: HR = 2.88, 95% CI 0.58–14.4, p = 0.20), possibly owing to the fact that the ASCT was given mainly to newly diagnosed patients as consolidation prior to relapse, and relapse is associated with poorer prognosis.
Notably, the smoking group showed a trend of higher wound morbidity and had a higher incidence of pneumonia (5.7% vs. 0.7%, p = 0.005).
Changes in flea bacterial loads over time showed a trend similar to that of prevalence and were significantly different (F = 3.148, P = 0.005) (Fig. 3 d).
eryngii showed a trend for dye loss over time (20 weeks vs. 7 weeks P = 0.005, 20 weeks vs. 12 weeks P = 0.035), and the change by 5 months was significantly different to the control ( P = 0.003) although to a lesser extent than P. ostreatus .
For example, S hominis LK2134, isolated from a control participant, showed a trend toward improved barrier function ( P adj = .12; P = .005), whereas S hominis LK2024, isolated from a lesional swab, showed the most detrimental effect on barrier function ( P adj < 1 × 10 −10 ).
Fisher's exact test showed an association between the tertiles in relation to the PI-RADS v2 (p = 0.003), however, a more thorough analysis showed a trend only in the case of Pi-RADS 3 vs. other (p = 0.005).
While human PCa FMT1 and FMT6 showed a trend to increase (734 ± 30% and 63 ± 22%, respectively) TRAMP-C2 tumour mass compared to autologous mouse FMT, FMT2, 3, 4 and 5 all led to bigger tumours (127 ± 4% p = 0.006, two-sided t -test, 199 ± 13% p = 0.007, two-sided t -test, 247 ± 26% p = 0.04, two-sided t -test and 166 ± 15% p = 0.01, two-sided t-test, respectively) in the recipient animals (Fig. 3c ).
PTX3 concentrations showed a trend toward increased levels at day 0 in non-survivors and this increase became significant at day 14 (2.7-fold induction; p = 0.0063), but normalized at day 28.